日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic Drugs

洛匹那韦衍生物作为强效P-gp抑制剂，可通过HPMA共聚物偶联物递送，克服肿瘤对传统细胞抑制剂的化疗耐药性。

期刊:Biomacromolecules
影响因子:5.4
doi:10.1021/acs.biomac.5c02097
Starenko, Daniil; Kostka, Libor; Behalova, Katerina; Kotrchova, Lenka; Subr, Vladimir; Kovarova, Jirina; Roubalova, Radka; Sirova, Milada; Etrych, Tomas; Kovar, Marek
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Effect of Cellular and Microenvironmental Multidrug Resistance on Tumor-Targeted Drug Delivery in Triple-Negative Breast cancer.

细胞和微环境多药耐药性对三阴性乳腺癌肿瘤靶向药物递送的影响

期刊:Journal of Controlled Release
影响因子:11.5
doi:10.1016/j.jconrel.2022.12.056
Tezcan Okan, Elshafei Asmaa Said, Benderski Karina, Rama Elena, Wagner Maike, Moeckel Diana, Pola Robert, Pechar Michal, Etrych Tomas, von Stillfried Saskia, Kiessling Fabian, Weiskirchen Ralf, Meurer Steffen, Lammers Twan
肿瘤
乳腺癌
发表日期：2023
文献求助 收藏

Targeted Drug Delivery and Theranostic Strategies in Malignant Lymphomas

恶性淋巴瘤的靶向药物递送和诊疗策略

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14030626
Etrych, Tomas; Braunova, Alena; Zogala, David; Lambert, Lukas; Renesova, Nicol; Klener, Pavel
淋巴瘤
发表日期：2022
文献求助 收藏

Augmentation of EPR Effect and Efficacy of Anticancer Nanomedicine by Carbon Monoxide Generating Agents

一氧化碳发生剂增强EPR效应及抗癌纳米药物疗效

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics11070343
Fang, Jun; Islam, Rayhanul; Islam, Waliul; Yin, Hongzhuan; Subr, Vladimir; Etrych, Tomas; Ulbrich, Karel; Maeda, Hiroshi
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Noninvasive optical imaging of nanomedicine biodistribution

纳米药物生物分布的非侵入性光学成像

期刊:ACS Nano
影响因子:16
doi:10.1021/nn303955n
Kunjachan, Sijumon; Gremse, Felix; Theek, Benjamin; Koczera, Patrick; Pola, Robert; Pechar, Michal; Etrych, Tomas; Ulbrich, Karel; Storm, Gert; Kiessling, Fabian; Lammers, Twan
发表日期：2013
文献求助 收藏